Lida Jouca De Assis Figueredo

Dr. Lida Jouca De Assis Figueredo


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
NDNayanne Gama Teixeira Dantas
Nayanne Gama Teixeira Dantas
PSPHILIP NOEL SUFFYS
PHILIP NOEL SUFFYS
WCWânia da Silva Carvalho
Wânia da Silva Carvalho
HGHarrison Magdinier Gomes
Harrison Magdinier Gomes
IAIsabela Neves de Almeida
Isabela Neves de Almeida
SMSILVANA SPINDOLA MIRANDA
SILVANA SPINDOLA MIRANDA
We aimed to characterize the genetic diversity of drug-resistant Mycobacterium tuberculosis (MTb) clinical isolates and investigate the molecular epidemiology of multidrug-resistant (MDR) tuberculosis from Minas Gerais State, Brazil. One hundred and four MTb clinical isolates were assessed by IS6110-RFLP, 24-locus mycobacterial interspersed repetitive units variable-number tandem repeats (MIRU-VNTR), TB-SPRINT (simultaneous spoligotyping and rifampicin-isoniazid drug-resistance mutation analysis) and 3R-SNP-typing (analysis of single-nucleotide polymorphisms in the genes involved in replication, recombination and repair functions). Fifty-seven different IS6110-RFLP patterns were found, among which 50 had unique patterns and 17 were grouped into seven clusters. The discriminatory index (Hunter and Gaston, HGDI) for RFLP was 0.9937. Ninety-nine different MIRU-VNTR patterns were found, 95 of which had unique patterns and nine isolates were grouped into four clusters. The major allelic diversity index in the MIRU-VNTR loci ranged from 0.6568 to 0.7789. The global HGDI for MIRU-VNTR was 0.9991. Thirty-two different spoligotyping profiles were found: 16 unique patterns (n = 16) and 16 clustered profiles (n = 88). The HGDI for spoligotyping was 0.9009. The spoligotyped clinical isolates were phylogenetically classified into Latin-American Mediterranean (66.34 %), T (14.42 %), Haarlem (5.76 %), X (1.92 %), S (1.92 %) and U (unknown profile; 8.65 %). Among the U isolates, 77.8 % were classified further by 3R-SNP-typing as 44.5 % Haarlem and 33.3 % LAM, while the 22.2 % remaining were not classified. Among the 104 clinical isolates, 86 were identified by TB-SPRINT as MDR, 12 were resistant to rifampicin only, one was resistant to isoniazid only, three were susceptible to both drugs, and two were not successfully amplified by PCR. A total of 42, 28 and eight isolates had mutations in rpoB positions 531, 526 and 516, respectively. Correlating the cluster analysis with the patient data did not suggest recent transmission of MDR-TB. Although our results do not suggest strong transmission of MDR-TB in Minas Gerais (using a classical 100 % MDR-TB identical isolates cluster definition), use of a smoother cluster definition (>85 % similarity) does not allow us to fully eliminate this possibility; hence, around 20–30 % of the isolates we analyzed might be MDR-TB transmission cases.

25 June 2019 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
IAIsabela Neves de Almeida
Isabela Neves de Almeida
SVSidra Vasconcelos
Sidra Vasconcelos
LFLida Jouca De Assis Figueredo
Lida Jouca De Assis Figueredo
NDNayanne Gama Teixeira Dantas
Nayanne Gama Teixeira Dantas
CACláudio José Augusto
Cláudio José Augusto
SMSILVANA SPINDOLA MIRANDA
SILVANA SPINDOLA MIRANDA
In recent decades, Mycobacterium tuberculosis with the RDRio genotype, frequently isolated from tuberculosis patients in Rio de Janeiro, has become part of the Latin American – Mediterranean (LAM) family and has been associated with multidrug-resistant tuberculosis (MDR-TB). The aim of this study was to investigate the frequency of M. tuberculosis RDRio in the state of Minas Gerais, Brazil, and its relationship with MDR-TB. For convenience, 172 susceptible and 63 MDR M. tuberculosis isolates were taken from pulmonary samples from patients diagnosed between January 2007 and December 2011. The DNA extracted from these isolates was analyzed by spoligotyping, PCR-RFLP to characterize fbpC103/Ag85C103, multiplex PCR to detect RDRio and RD174, and MIRU-VNTR 24 loci. Among the 235 isolates, the RDRio pattern was identified in 122 (51.9%) isolates (IC 0.45–0.58), with 100 (42.5%) wild-type and 13 (5.5%) mixed pattern isolates, whereas RD174 was identified in 93 of the 122 RDRio positive samples (76.3%). The LAM family and the LAM9 lineage were the most frequently identified among the isolates in this study. Among the 63 MDR isolates, 41 (65.1%) were RDRio and 28 (44.4%) RD174. The association of both deletions with MDR proved to be statistically significant, corroborating the few reports that have associated RDRio with MDR.

1 January 2020 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
VSValéria Martins Soares
Valéria Martins Soares
IAIsabela Neves De Almeida
Isabela Neves De Almeida
LFLida Jouca De Assis Figueredo
Lida Jouca De Assis Figueredo
JHJoão Paulo Amaral Haddad
João Paulo Amaral Haddad
COCamila Stefanie Fonseca de Oliveira
Camila Stefanie Fonseca de Oliveira
SMSILVANA SPINDOLA MIRANDA
SILVANA SPINDOLA MIRANDA
To evaluate the risk factors for the development of tuberculosis and multidrug-resistant tuberculosis (MDR-TB) in patients treated at a tertiary referral hospital. This was a cross-sectional study based on data obtained from patients treated at the Júlia Kubitschek Hospital, located in the city of Belo Horizonte, Brazil, between October of 2012 and October of 2014. We evaluated sociodemographic, behavioral, clinical, and radiological variables. The outcome considered to identify associations between tuberculosis and the explanatory variables was the treatment prescribed. To evaluate the associations between MDR-TB and the same explanatory variables, the change in MDR-TB treatment was considered. The factors associated with tuberculosis were alcoholism, comorbidities, pulmonary cavitations, and a radiological pattern suggestive of tuberculosis. Cavitation and previous treatment for tuberculosis were associated with MDR-TB. Despite the significant progress made in the fight against tuberculosis, there is a need for coordinated actions that include social protection measures and patient support.

1 January 2023 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
PDF file
GBGrazielle Conceição Sousa Barboza
Grazielle Conceição Sousa Barboza
IAIsabela Neves de Almeida
Isabela Neves de Almeida
LSLucas Benício dos Santos
Lucas Benício dos Santos
CAClaudio José Augusto
Claudio José Augusto
ÉLÉlida Aparecida Leal
Élida Aparecida Leal
LFLida Jouca De Assis Figueredo
Lida Jouca De Assis Figueredo
The incidence and clinical characteristics of NTM diseases in Brazil remain relatively unknown. The present study describes the diagnosis of NTM isolates, the clinical presentation and treatment outcomes. We analyzed NTM isolates in patients of a tertiary hospital in the Southeast region of Brazil, from January 2008 to July 2019. The ATS/IDSA criteria for diagnosis and treatment of these patients was applied. Mycobacterium kansasii were identified in 13/113 (11.5%) patients. In 59/113 (52.2%) patients who met the ATS criteria for disease, 29/59 (49.1%) received treatment, and 22/29 (75.8%) were cured. The major species identified was M. kansasii. The most frequent symptoms among the treated patients were dyspnea and cough, and the proportion of cured patients was high.

1 May 2025 in Journal of Medical Imaging
Verified
Journal Article
Closed access
JGJoão Victor Boechat Gomide
João Victor Boechat Gomide
TCThales Francisco Mota Carvalho
Thales Francisco Mota Carvalho
ÉLÉlida Aparecida Leal
Élida Aparecida Leal
LFLida Jouca De Assis Figueredo
Lida Jouca De Assis Figueredo
NBNauhara Vieira de Castro Barroso
Nauhara Vieira de Castro Barroso
CACláudio José Augusto
Cláudio José Augusto
PurposeWe aim to provide a robust dataset for training automated systems to detect tuberculosis bacilli using Ziehl–Neelsen stained slides. By making this dataset available, a critical gap in the availability of public datasets that can be used for developing and testing artificial intelligence techniques for tuberculosis diagnosis is addressed. Our rationale is grounded in the urgent need for diagnostic tools that can enhance tuberculosis diagnosis quickly and efficiently, especially in resource-limited settings.ApproachThe Ziehl–Neelsen method was used to prepare 362 slides, which were manually read. According to the World Health Organization’s guidelines for performing bacilloscopy for tuberculosis diagnosis, experts annotated each slide to diagnose it as negative or positive. In addition, selected images underwent a detailed annotation process aimed at pinpointing the location of each bacillus and cluster within each image.ResultsThe database consists of three directories. The first contains all the images, separated by slide, and indicates whether it is negative or the number of crosses if positive, for each slide. The second directory contains the 502 images selected for training automated systems, with each bacillus’s position annotated and the Python code used. All the image fragments (positive and negative patches) used in the models’ training, validation, and testing stages are available in the third directory.ConclusionsThe development of this annotated image database represents a significant advancement in tuberculosis diagnosis. By providing a high-quality and accessible resource to the scientific community, we enhance existing diagnostic tools and facilitate the development of automated technologies.

1 January 2023 in Revista da Sociedade Brasileira de Medicina Tropical
Verified
Journal Article
Open access
PDF file
LFLida Jouca De Assis Figueredo
Lida Jouca De Assis Figueredo
ACAina Liz Alves César
Aina Liz Alves César
LFLucilaine Ferrazoli
Lucilaine Ferrazoli
ECErica Chimara
Erica Chimara
MVMaria Claudia Vater
Maria Claudia Vater
SMSILVANA SPINDOLA MIRANDA
SILVANA SPINDOLA MIRANDA
We aimed to evaluate the costs of GenoType® MTBDRplus and MTBDRsl incurred during the diagnosis of first- and second-line drug-resistant tuberculosis (TB) in São Paulo, Brazil.